A Settlement has been reached in a lawsuit with the manufacturer of the weed-killer Imprelis®. The lawsuit claims that Imprelis® killed and damaged trees and other non-target vegetation.
Imprelis® was used by lawn care professionals on residential and commercial properties, as well as by golf courses, between August 31, 2010 and August 21, 2011. It was used in every state, except California and New York.
This Settlement will provide benefits to consumers and businesses with tree damage caused by Imprelis®.
To view Multimedia News Release, go to http://www.multivu.com/players/English/60753-imprelis-tree-damage-settlement
The following statement is being issued by Jonathan Schochor, Chairman, Plaintiffs’ Steering Committee, regarding Jane Doe No. 1, et. al. v. Johns Hopkins Hospital, et al., No. 24-C-13-001041.
If you were a patient of, or treated by Johns Hopkins Hospital gynecologist, Dr. Nikita Levy, you are a member of a mandatory settlement class action.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/65136-dr-nikita-levy-class-action-lawsuit-johns-hopkins-hospital-gynecology
The following is being released by the Notice Provider, Kinsella Media, LLC, about the lawsuit In re Automotive Parts Antitrust Litigation, MDL No. 2311.
There is an update for affected purchasers in this lawsuit about certain motor vehicle components, as there have been additional Settlements that may affect their rights.
Settlements totaling approximately $225 million have now been reached with eleven Defendants. The lawsuits allege that they fixed the price of certain motor vehicle components, causing millions of consumers and businesses from around the country to overpay for new or leased automobiles and replacement parts, such as air flow meters, alternators, ATF warmers, automotive wire harness systems, electronic throttle bodies, fuel injection systems, fuel senders, heater control panels, high intensity discharge ballasts, ignition coils, instrument panel clusters, inverters, motor generators, occupant safety restraint systems, radiators, starters, steering angle sensors, switches, and valve timing control devices.
To view the multimedia release go to:
http://www.multivu.com/players/English/7755651-auto-parts-antitrust-update/
The following statement is being issued by Branstetter, Stranch & Jennings, PLLC regarding In re Prograf Antitrust Litigation.
A lawsuit is currently pending claiming that Astellas Pharma US, Inc. (“Astellas” or “Defendant”) violated state antitrust, unfair competition, consumer protection, and unjust enrichment laws of certain states by delaying the availability of a less expensive generic version of the immunosuppressant prescription drug Prograf® (known as tacrolimus). Plaintiffs allege that Defendant’s conduct caused some consumers and third party payors to pay too much for Prograf in certain states from September 3, 2008 to December 31, 2010 (also referred to as the “Class Damage Period”). This lawsuit does not claim that Prograf is unsafe or ineffective. Astellas denies any wrongdoing.
To view the multimedia release go to:
http://www.multivu.com/players/English/7933851-prograf-antitrust-class-action-settlement/
The following is being released by the Notice Provider, Kinsella Media, LLC, about the lawsuit In re Automotive Parts Antitrust Litigation, MDL No. 2311.
There is an update for affected purchasers in this lawsuit about certain vehicle components, as there have been additional Settlements that may affect their rights.
Twelve additional Defendants have agreed to Settlements resolving claims that they fixed the price of certain vehicle components. (The Court previously approved settlements with 11 Defendants, totaling approximately $225 million.) The additional Settlements being presented for Court Approval total approximately $379 million.
The lawsuits allege that Defendants fixed the price of certain vehicle components, causing millions of consumers and businesses from around the country to pay more for certain new or leased vehicles and replacement parts. A complete list of included parts is available at the website, www.AutoPartsClass.com.
To view the multimedia release go to:
http://www.multivu.com/players/English/7982351-auto-parts-class-action-settlements/
Ten leading electronics manufacturers have settled lawsuits involving an illegal conspiracy to raise prices for the LCD flat panel screens used in televisions, monitors, and laptop computers. The class action Settlements total approximately $1.1 billion and provide cash back to consumers and businesses that bought widely used LCD (thin-film transistor liquid crystal display) screens.
To view Multimedia News Release, go to http://www.multivu.com/players/English/58577-lcd-price-fixing-class-action-settlement/
Vioxx Settlement
This is an important announcement for consumers about the prescription drug Vioxx. Vioxx was a drug commonly used to treat pain and inflammation in adults with arthritis.
A settlement was reached with the manufacturer of Vioxx and will provide refunds to anyone who paid for the medication. Consumers are eligible to get $50 or more. Personal injury claims related to this drug are not included in this settlement.
The deadline to file a claim is approaching – claims must be filed by May 6, 2014.
Details are available at http://www.VioxxSettlement.com or by calling 1-866-439-6932.
Settlements have been reached in class action lawsuits involving the Huronia Regional Centre (“Huronia”), Rideau Regional Centre (“Rideau”), and Southwestern Regional Centre (“Southwestern”) which were residential facilities operated by the Province of Ontario (the “Province”) that provided care and support to persons with developmental disabilities from 1876 to 2009.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/7161751-koskie-minsky-huronia-rideau-southwestern-class-action-settlements
The following statement is being issued by Jonathan Schochor, Chairman, Plaintiffs’ Steering Committee, regarding Jane Doe No. 1, et. al. v. Johns Hopkins Hospital, et al., No. 24-C-13-001041.
If you were a patient of, or were treated by Johns Hopkins Hospital gynecologist, Dr. Nikita Levy, you may be eligible for compensation from a class action Settlement
A $190 million dollar proposed Settlement has been reached that offers payments to eligible members of The Levy Settlement Class.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7281851-dr-nikita-levy-patients-class-action-settlement/
The following statement is being issued by Block & Leviton LLP, Finkelstein Thompson LLP and Green & Noblin PC regarding the Drywall Antitrust Litigation.
If you purchased Wallboard INDIRECTLY from one or more of the companies listed below, your rights may be affected by proposed Settlements
Proposed class settlements totaling $10.5 million have been reached with two Defendants in In re Domestic Drywall Antitrust Litigation, MDL No. 2437 and 13-MD-2437, pending in the U.S. District Court for the Eastern District of Pennsylvania.
If you purchased for end use wallboard manufactured and/or distributed by CertainTeed Gypsum, Inc., USG Corporation, United States Gypsum Company, New NGC, Inc., Lafarge North America, Inc., Eagle Materials, Inc., American Gypsum Company LLC, PABCO Building Products, LLC, TIN, Inc., or their subsidiaries (collectively, the “Defendants”), between January 1, 2012 and November 30, 2014, you may be a class member. “Wallboard” means paper-backed gypsum wallboard, also called drywall or plasterboard.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7449651-drywall-class-action-settlement/
A Settlement has been reached in a bankruptcy involving claims about exposure to asbestos-containing gasket and packing products. Garlock Sealing Technologies LLC, The Anchor Packing Company, and Garrison Litigation Management Group, Ltd. (“Debtors”) have filed a plan of reorganization to restructure their business and pay claims.
The products (with names like Garlock, Blue-Gard, Gylon, and Flexseal) were used in places where steam, hot liquid or acids moved through pipes, including in shipbuilding, oil refinery, chemical, paper and pulp, semi-conductor, power, and construction industries as well as in maritime/naval vessels.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7476251-garlock-bankruptcy-asbestos/
